Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title previous answer version answering member constituency answering member printed answering member
tabling member	label

Search

1504262

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Junior Doctors: Pay
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of awarding NHS junior doctors a higher pay rise than set out in the agreed 2019 four-year pay settlement in the context of the rising cost of living.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	45809
	answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>Junior doctors have a pre-existing multi-year pay and contract reform deal agreed with the trade union. As well as setting annual pay increases, the deal made improvements to terms and conditions and further strengthened safety and rest limits. Alongside investment in pay, the Government has also invested £90 million to create a new higher pay point for the most experienced junior doctors, increase allowances for those working the most frequently at weekends, enhance eligibility for night shift pay and create a £1,000 a year allowance for junior doctors working less than full time to help with the cost of training. The multi-year deal ends in 2023 and the Government will consider next year’s pay increase with evidence on recruitment and retention.</p> answering member constituency Newark answering member printed Robert Jenrick grouped question UIN 45810 question first answered 22/09/2022 14:18:31 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4079 label Biography information for Julian Sturdy

1504263

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Junior Doctors: Pay
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the impact on retention of junior doctors by the NHS of limiting 2022 pay rises to the amount set out in the 2019 four-year pay settlement.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	45810
	answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>Junior doctors have a pre-existing multi-year pay and contract reform deal agreed with the trade union. As well as setting annual pay increases, the deal made improvements to terms and conditions and further strengthened safety and rest limits. Alongside investment in pay, the Government has also invested £90 million to create a new higher pay point for the most experienced junior doctors, increase allowances for those working the most frequently at weekends, enhance eligibility for night shift pay and create a £1,000 a year allowance for junior doctors working less than full time to help with the cost of training. The multi-year deal ends in 2023 and the Government will consider next year’s pay increase with evidence on recruitment and retention.</p> answering member constituency Newark answering member printed Robert Jenrick grouped question UIN 45809 question first answered 22/09/2022 14:18:31 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4079 label Biography information for Julian Sturdy

1505830

	registered interest
	date	07/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Evusheld
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment the UK Health Security Agency of the effectiveness of the drug Evusheld against the Omicron variant of covid-19; and if she will make that treatment available on the NHS to people who are immunocompromised.
	tabling member constituency	Ynys Môn
	tabling member printed	Virginia Crosbie
	uin	49297
	answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>The Government has decided not to procure Evusheld for prevention through emergency routes at this time. This is a decision based on independent clinical advice by the multi-agency RAPID C-19 and a national expert policy working group, which considered a range of evidence, including clinical trial data, in vitro analysis and emerging observational studies. It concluded that there is currently insufficient evidence of benefit to recommend deployment at this time.  The Chief Medical Officer for England is content that the correct process for providing clinical advice has been followed and agrees that it should now be referred to the National Institute for Health and Care Excellence for further evaluation.</p><p> </p><p>The Department wrote to patient groups on 5 September 2022 with information on this decision and evidence considered. The Department intends to publish further details of the clinical advice received shortly.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 22/09/2022 13:56:17 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4859 label Biography information for Virginia Crosbie

1505868

	registered interest
	date	07/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Members: Correspondence
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when she plans to respond to the letter of 24 June 2022 from the hon. member for West Lancashire on staffing levels in clinical radiology and clinical oncology, reference ZA60022.
	tabling member constituency	West Lancashire
	tabling member printed	Rosie Cooper
	uin	49103
	answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>We replied to the hon. Member on 19 August 2022.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 22/09/2022 14:01:42 answering member 4320 label Biography information for Robert Jenrick
	tabling member	1538 label Biography information for Rosie Cooper

1506237

	registered interest
	date	08/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dementia: Clinical Trials
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many (a) phase I, (b) phase II and (c) phase III clinical trials for dementia have been hosted in Wales in each of the last 10 years.
	tabling member constituency	Vale of Clwyd
	tabling member printed	Dr James Davies
	uin	49731
	answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>The information requested on clinical trials hosted in Wales and Scotland is not held centrally. A table showing the number of phase one, two and three clinical trials supported by the National Institute for Health and Social Care Research Clinical Research Network in England for dementia from 2012/13 to 2021/22 is attached.</p> answering member constituency Newark answering member printed Robert Jenrick grouped question UIN 49792 question first answered 22/09/2022 08:33:32 answering member 4320 label Biography information for Robert Jenrick attachment 1 file name Formatted TABLE PQ 49792 attachment.docx title Dementia clinical trials in England 2012 to 2022
	tabling member	4476 label Biography information for Dr James Davies

1503839

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Emergency Calls and NHS 111
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of levels of public knowledge of (a) the roles and purposes of 999 and NHS 111 and (b) when it is appropriate to contact each service respectively.
	tabling member constituency	Twickenham
	tabling member printed	Munira Wilson
	uin	45587
	answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>No formal assessment has been made.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 22/09/2022 14:09:50 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4776 label Biography information for Munira Wilson

1504538

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Out of Area Treatment: Travel
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if his Department will take steps to reimburse friends and family members who travel long distances to visit NHS patients whose care has been moved to a new location.
	tabling member constituency	Tamworth
	tabling member printed	Christopher Pincher
	uin	45794
	answer	answer is ministerial correction date of answer 21/09/2022 answer text <p>The Government has no plans to do so.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 21/09/2022 13:55:34 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4075 label Biography information for Christopher Pincher

1506046

	registered interest
	date	07/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Database
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if the Government will introduce provisions to ensure that meaningful and informed consent is sought from each patient before any of their health or social care data is transferred onto the Federated Data Platform.
	tabling member constituency	Norwich South
	tabling member printed	Clive Lewis
	uin	49205
	answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>Data on the Federated Data Platform (FDP) will be transferred from existing data sets, which have a lawful basis for collection and processing. Therefore, seeking the consent of individuals for the transfer of these datasets will not be required. NHS England is committed to transparency on the way data is used within the FDP to ensure that patients are informed of the choice to opt out, where applicable and how to do so. It is also committed to publishing information on who is accessing data and for what purpose.</p><p>Data protection law and the common law duty of confidentiality will continue to apply. There must always be a valid lawful basis for the collection and processing of personal information, with transparency about the use of data within federated data platforms, as defined under the applicable legislation. The FDP will be used as separate instances to provide access to data for both the primary use of data, such as direct patient care and the secondary use of data, such as its use in analysis and planning. This will be based on specific use cases which set out the data specification and data classification and access controls which will be used. Where confidential patient information is being used to support direct care within the FDP, explicit consent would not be required as this data has implied consent for use.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 22/09/2022 13:43:05 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4500 label Biography information for Clive Lewis

1505163

	registered interest
	date	05/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Evusheld
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when he expects NICE's review of Evusheld to be concluded.
	tabling member constituency	North Durham
	tabling member printed	Mr Kevan Jones
	uin	47379
	answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>On 10 August 2022, the Department referred tixagevimab and cilgavimab (Evusheld) to the National Institute for Health and Care Excellence (NICE) to evaluate its clinical and cost effectiveness for preventing COVID-19. Between 29 July and 12 August, NICE consulted with stakeholders on the suggested remit, draft scope and list of consultees and commentators.</p><p>NICE has commenced this evaluation and currently expects to publish draft guidance in April 2023, with final guidance to follow in May 2023. In discussion with AstraZeneca, NICE is expediting the appraisal process by bringing forward the deadline for the manufacturer’s evidence submission.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 20/09/2022 14:34:16 answering member 4320 label Biography information for Robert Jenrick previous answer version 17716 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
	tabling member	1438 label Biography information for Mr Kevan Jones

1505900

	registered interest
	date	07/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Anaesthesia Associates and Physician Associates: Regulation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 6 June 2022 to Question 7493 on Anaesthesia Associates and Physician Associates: Regulation, if she will set out a timetable for bringing forward legislative proposals on the regulation of physician associates and anaesthesia associates; and if she will make a statement.
	tabling member constituency	Newport East
	tabling member printed	Jessica Morden
	uin	49105
	answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>We plan to publish the public consultation on the draft legislation which will enable the General Medical Council (GMC) to regulate physician associates (PAs) and anaesthesia associates (AAs) in the autumn. Following this consultation, we will finalise the legislation to be laid in the second half of 2023, subject to Parliamentary time. The GMC will then develop and implement its rules and processes for regulating PAs and AAs within 12 months, enabling regulation to commence in the second half of 2024.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 22/09/2022 13:42:47 answering member 4320 label Biography information for Robert Jenrick
	tabling member	1548 label Biography information for Jessica Morden